CCNYL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.815800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.041400E-01
Normal-vs-Stage2
8.507000E-01
Normal-vs-Stage3
2.260000E-01
Normal-vs-Stage4
4.944200E-01
Stage1-vs-Stage2
3.024600E-01
Stage1-vs-Stage3
7.765000E-01
Stage1-vs-Stage4
1.594850E-01
Stage2-vs-Stage3
2.932200E-01
Stage2-vs-Stage4
6.934200E-01
Stage3-vs-Stage4
1.343570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.977200E-01
Normal-vs-AfricanAmerican
6.749600E-01
Normal-vs-Asian
8.023200E-01
Caucasian-vs-AfricanAmerican
5.754800E-01
Caucasian-vs-Asian
6.639400E-01
AfricanAmerican-vs-Asian
4.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.638600E-01
Normal-vs-Female
9.165800E-01
Male-vs-Female
5.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.755600E-01
Normal-vs-Age(41-60Yrs)
7.311200E-01
Normal-vs-Age(61-80Yrs)
9.216800E-01
Normal-vs-Age(81-100Yrs)
5.386000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.225800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.441600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.521800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.087850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.561180E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.321600E-01
Normal-vs-Daily Drinker
4.605200E-01
Normal-vs-Weekly Drinker
5.536800E-01
Normal-vs-Occasional Drinker
9.538800E-01
Normal-vs-Social Drinker
9.019200E-01
Non Drinker-vs-Daily Drinker
3.154800E-01
Non Drinker-vs-Weekly Drinker
4.698200E-01
Non Drinker-vs-Occasional Drinker
7.617600E-01
Non Drinker-vs-Social Drinker
7.031200E-01
Daily Drinker-vs-Weekly Drinker
1.697630E-01
Daily Drinker-vs-Occasional Drinker
1.239030E-01
Daily Drinker-vs-Social Drinker
1.693400E-01
Weekly Drinker-vs-Occasional Drinker
6.097000E-01
Weekly Drinker-vs-Social Drinker
7.372600E-01
Occasional Drinker-vs-Social Drinker
8.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.000800E-01
Normal-vs-Grade 2
7.341900E-02
Normal-vs-Grade 3
1.506440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.104800E-03
Grade 1-vs-Grade 3
1.223510E-02
Grade 1-vs-Grade 4
4.000800E-01
Grade 2-vs-Grade 3
3.717800E-01
Grade 2-vs-Grade 4
7.341900E-02
Grade 3-vs-Grade 4
1.506440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.883000E-01
Normal-vs-NonDiabetic
9.433200E-01
Diabetic-vs-NonDiabetic
8.384400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.064800E-01
Normal-vs-NoPancreatitis
9.435800E-01
Pancreatitis-vs-NoPancreatitis
6.316800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.455400E-01
Normal-vs-N1
8.518600E-01
N0-vs-N1
8.600300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.055000E-01
Normal-vs-TP53-NonMutant
1.952610E-01
TP53-Mutant-vs-TP53-NonMutant
1.238290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
